MedPath

study of the combination of dexmedetomidine-propofol, dexmedetomidine and propofol for sedatio

Phase 3
Recruiting
Conditions
eed for sedation during mechanical ventilation.
Registration Number
IRCT20160307026950N54
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Age over 18 years and under 70 mechanical ventilation hospitalized in the intensive care unit, Glasgow coma number is less than 9.

Exclusion Criteria

Patients with contraindications to dexmedetomidine and propofol
Patients with serious mental disorders and dementia
People with acute infectious diseases or severe underlying diseases including liver dysfunction, cardiovascular disorders including heart block, heart rate = 60, heart failure with ejection fraction = 30%, diabetes or severe blood pressure (120/180)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation rate of patients. Timepoint: At the base time (before the start of the intervention) and then every 24 hours. Method of measurement: The level of patient sedation will be evaluated using the Ramsay criterion, whose validity and reliability have been confirmed by a recent study.
Secondary Outcome Measures
NameTimeMethod
Mean arterial pressure. Timepoint: Baseline time (before the start of the intervention) then every 6 hours. Method of measurement: barometer.;Heart Rate. Timepoint: Baseline time (before the start of the intervention) then every 6 hours. Method of measurement: ECG.;Arterial blood oxygen saturation. Timepoint: Baseline time (before the start of the intervention) then every 6 hours. Method of measurement: pulse oximeter.;Blood pressure. Timepoint: Baseline time (before the start of the intervention) then every 6 hours. Method of measurement: Barometer.
© Copyright 2025. All Rights Reserved by MedPath